EBR Systems (EBRCZ) Current Deferred Revenue (2025 - 2026)
EBR Systems' (EBRCZ) quarterly Current Deferred Revenue came in at $1.1 million in Q1 2026, up 119.12% quarter-over-quarter from $502000.0 in Q4 2025.
Powered by 
Analysis
EBR Systems (EBRCZ) Current Deferred Revenue (2025 - 2026) Analysis & Trends
EBR Systems has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $1.1 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $502000.0, changed N/A from the prior year.
- Current Deferred Revenue came in at $1.1 million for Q1 2026 at EBR Systems, up from $502000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q1 2026 to a low of $502000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | EBR Systems | 10.83 Mn | 10.83 Mn | - |